Pedro Fidalgo
Overview
Explore the profile of Pedro Fidalgo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fidalgo P, Povoa P, Germano N, Karvellas C, Cardoso F
GE Port J Gastroenterol
. 2024 Oct;
31(5):351-359.
PMID: 39360167
Introduction: Acute liver failure (ALF) is a rare disease with high mortality. Acute kidney injury (AKI) following ALF is frequent. We assessed AKI impact on long-term kidney function among ALF...
2.
Cardoso F, Toapanta D, Jimenez N, Fidalgo P, Figueiredo A, Valdivieso M, et al.
Liver Int
. 2024 Jul;
44(10):2651-2659.
PMID: 39016195
Background & Aims: Ammonia is metabolized into urea in the liver. In acute liver failure (ALF), ammonia has been associated with survival. However, urea variation has been poorly studied. Methods:...
3.
Duarte T, Fidalgo P, Karvellas C, Cardoso F
J Crit Care
. 2023 Nov;
81:154456.
PMID: 37945461
Purpose: Acute liver failure (ALF) or acute-on-chronic liver failure (ACLF) patients have high short-term mortality and morbidity. In the context of liver failure, increased serum ammonia is associated with worse...
4.
Cardoso F, Kim M, Pereira R, Bagulho L, Fidalgo P, Pawlowski A, et al.
Aliment Pharmacol Ther
. 2023 Oct;
58(9):962-963.
PMID: 37831530
No abstract available.
5.
Cardoso F, Kim M, Pereira R, Bagulho L, Fidalgo P, Pawlowski A, et al.
Aliment Pharmacol Ther
. 2023 Jul;
58(7):715-724.
PMID: 37470277
Background: Serum ammonia variation in critically ill patients with cirrhosis has been poorly studied. Aim: To describe and assess the impact of serum ammonia variation in these patients' outcomes. Methods:...
6.
Fidalgo P, Verissimo R, Cardoso F
Nefrologia (Engl Ed)
. 2022 Oct;
42(3):360-362.
PMID: 36210126
No abstract available.
7.
Cidade J, Coelho L, Costa V, Morais R, Moniz P, Morais L, et al.
World J Crit Care Med
. 2022 Sep;
11(4):246-254.
PMID: 36051940
Background: Coronavirus disease 2019 (COVID-19) can be associated with life-threatening organ dysfunction due to septic shock, frequently requiring intensive care unit (ICU) admission, respiratory and vasopressor support. Therefore, clear clinical...
8.
Cardoso F, Fidalgo P, Bagshaw S, Gottfried M, Tujios S, Olson J, et al.
Crit Care Med
. 2022 Apr;
50(9):1329-1338.
PMID: 35446272
Objectives: Acute liver failure (ALF) is an orphan disease often complicated by acute kidney injury (AKI). We assessed the impact of transient versus persistent AKI on survival in patients with...
9.
Carrilho P, Fidalgo P, Lima A, Bastos L, Soares E, Manso R, et al.
EBioMedicine
. 2022 Mar;
77:103921.
PMID: 35272260
Background: Magnetic resonance liver scans indicate that iron overload is common in haemodialysis (HD) patients. However, histological evidence is scarce. Methods: Liver biopsy and bone marrow aspirate were obtained in...
10.
Fidalgo P, Nora D, Coelho L, Povoa P
J Clin Med
. 2022 Feb;
11(4).
PMID: 35207355
Sepsis is a life-threatening syndrome characterized by a dysregulated host response to an infection that may evolve rapidly into septic shock and multiple organ failure. Management of sepsis relies on...